Manufacturers say the current shortage is among the worst they have experienced since the popular, wide-ranging treatment came to market. In other pharmaceutical news: Sen. Bill Cassidy (R-La.) touts value-based payments for cutting drug costs; a new approach to gene therapy offers tentative hope; a controversy arises over a pre-term birth medication; and more.
from Kaiser Health News https://ift.tt/2oORPx3
November 05, 2019
Rose
Health News, Kaiser Health News
No comments
Related Posts:
First Edition: December 3, 2018Today's early morning highlights from the major news organizations. from Kaiser Health News https://ift.tt/2Rx4kWX … Read More
Readers And Tweeters Demand Action On Gun Violence, Mental Health Care OptionsLetters to the Editor is a periodic feature. We welcome all comments and will publish a selection. We edit for length and clarity and require full names. Behind The Bloodshed In 2018 alone, there have been more tha… Read More
Perspectives: Gene-Editing On Human Babies Was Highly Irresponsible; Allow Use Of CRISPR In EmbryosOpinion writers express views about gene-editing. from Kaiser Health News https://ift.tt/2PkSj5m … Read More
Feds Order More Weekend Inspections Of Nursing Homes To Catch Understaffing… Read More
Medicare Cuts Payments To Nursing Homes Whose Patients Keep Ending Up In Hospital… Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment